Phase 3 Atopic Dermatitis Clinical Trials
13 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–13 of 13 trials
Recruiting
Phase 3
A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic Dermatitis
Atopic Dermatitis
Organon and Co180 enrolled48 locationsNCT07265479
Recruiting
Phase 3
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
Atopic Dermatitis
AbbVie200 enrolled124 locationsNCT06389136
Recruiting
Phase 3
A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
Atopic Dermatitis
Pfizer500 enrolled31 locationsNCT06807281
Recruiting
Phase 3
A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
Atopic Dermatitis
AbbVie675 enrolled148 locationsNCT06461897
Recruiting
Phase 3
A Study of SHR-1819 Injection in Adolescents With Severe Atopic Dermatitis
Adolescents With Moderate-to-severe Atopic Dermatitis
Guangdong Hengrui Pharmaceutical Co., Ltd201 enrolled2 locationsNCT07309055
Recruiting
Phase 3
A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
Atopic Dermatitis
LEO Pharma195 enrolled72 locationsNCT06311682
Recruiting
Phase 3
A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children and Adolescents (6 to <18 Years Old) With Moderate Atopic Dermatitis
Atopic Dermatitis
Incyte Corporation240 enrolled96 locationsNCT06832618
Recruiting
Phase 3
ICP-332 in Subjects With Moderate to Severe Atopic Dermatitis
Atopic Dermatitis
Beijing InnoCare Pharma Tech Co., Ltd.552 enrolled62 locationsNCT06775860
Recruiting
Phase 3
Efficacy and Safety Study of QLM3003 Ointment in Participants With Mild or Moderate Atopic Dermatitis
Atopic Dermatitis
Qilu Pharmaceutical Co., Ltd.360 enrolled1 locationNCT06880276
Recruiting
Phase 3
A Study to Assess the Efficacy and Safety of PG-011 Gel in Adolescents and Adults With Atopic Dermatitis
Atopic Dermatitis
Prime Gene Therapeutics Co., Ltd.472 enrolled1 locationNCT06587685
Recruiting
Phase 2Phase 3
Herbal Ointment in Treating Atopic Dermatitis Topically
Atopic DermatitisAtopic Dermatitis (AD)
En Chu Kong Hospital66 enrolled1 locationNCT06850311
Recruiting
Phase 3
A Phase III Study to Evaluate the Efficacy and Safety of AK120 in Patients With Moderate to Severe Atopic Dermatitis
Atopic Dermatitis
Akeso420 enrolled59 locationsNCT06383468
Recruiting
Phase 2Phase 3
Vitamin D in the management of Childhood Atopic Dermatitis (eczema)
Atopic Dermatitis
Prof Dianne Campbell150 enrolled1 locationACTRN12612000570886